Publications Database

Ghaleiha A. et al. (2015)

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

Psychiatry Research

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.

Journal of Psychopharmacology

October, 28(7), pp. 677-685.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

International Journal of Neuropsycholpharmacology

16(4), pp. 783-789.

Read Abstract (New Window)

Ghanizadeh A. , Moghimi-Sarani E. (2013)

A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders.

BMC Psychiatry

13(1), pp. 196.

Read Abstract (New Window) Read Full (New Window)

Ghuman J. K. et al. (2009)

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit hyperactivity disorder symptoms in preschoolers with developmental disorders.

Journal of Child and Adolescent Psychopharmacology

19(4), pp. 329-339.

Read Abstract (New Window) Read Full (New Window)

Gillberg C. et al. (1986)

Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX).

Developmental Medicine and Child Neurology

28(5), pp. 624-627

Read Abstract (New Window)

Gordon C. T. et al. (1993)

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

Archives of General Psychiatry

50(6), pp. 441-447.

Read Abstract (New Window)

Gordon C. T. et al. (1992)

Differential response of seven subjects with autistic disorder to clomipramine and desipramine.

American Journal of Psychiatry

149(3), pp. 363-366.

Read Abstract (New Window)

Gordon I. et al. (2013)

Oxytocin enhances brain function in children with autism.

Proceedings of the National Academy of Science U S A

110(52), pp. 20953-20958.

Read Abstract (New Window) Read Full (New Window)

Granpeesheh D. et al. (2010)

Randomized trial of hyperbaric oxygen therapy for children with autism.

Research in Autism Spectrum Disorders

4(2), pp. 268-275

Read Abstract (New Window)

Grant P. J. et al. (2014)

12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder.

Neuropsychopharmacology

March, 39(6), pp. 1453-1459.

Read Abstract (New Window)

Gringras P. et al. (2017)

Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 56(11), pp. 948-957.

Read Abstract (New Window) Read Full (New Window)

Gringras P. et al. (2012)

Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.

British Medical Journal

345 e6664

Read Full (New Window)

Guastella A. J. et al. (2010)

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Biological Psychiatry

67(7), pp. 692-694

Read Abstract (New Window)

Guastella A. J. et al. (2015)

The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.

Journal of Child Psychology and Psychiatry

April, 56(4), pp. 444-452.

Read Abstract (New Window)

Handen B. L. et al. (2015)

Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention deficit hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 54(11), pp. 905-915.

Read Abstract (New Window)

Handen B. L. , Johnson C. R. , Lubetsky M. J. (2000)

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Journal of Autism and Developmental Disorders

30(3), pp. 245-255

Read Abstract (New Window)

Handen B. L. , Sahl R. , Hardan A. Y. (2008)

Guanfacine in children with autism and/or intellectual disabilities.

Journal of Developmental and Behavioral Pediatrics

29(4), pp. 303-308

Read Abstract (New Window)

Handen B. L. et al. (2011)

Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Journal of Child and Adolescent Psychopharmacology

February, 21(1), pp. 43-50

Read Abstract (New Window) Read Full (New Window)

Handen B. L. , Hofkosh D. (2005)

Secretin in children with autistic disorder: A double-blind, placebo-controlled trial.

Journal of Developmental and Physical Disabilities

June, 17(2), pp. 95-106.

Read Abstract (New Window)